Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Keros Therapeutics, Inc.
23 Feb 24
4
Keros Therapeutics, Inc.
15 Feb 24
4
Keros Therapeutics, Inc.
11 Apr 23
4
Keros Therapeutics, Inc.
17 Feb 23
4
Eloxx Pharmaceuticals, Inc.
17 Jun 22
4
Keros Therapeutics, Inc.
10 Jun 22
4
Keros Therapeutics, Inc.
25 Jan 22
4
Eloxx Pharmaceuticals, Inc.
20 May 21
4
Keros Therapeutics, Inc.
12 Jan 21
4
Eloxx Pharmaceuticals, Inc.
22 May 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
13 Feb 24 | KROS Keros Therapeutics | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 56.18 | 125,000 | 7.02 mm | 125,000 |
8 Apr 23 | KROS Keros Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0.48 | 4,000 | 1.92 k | 252,856 |
8 Apr 23 | KROS Keros Therapeutics | Employee Stock Option Common Stock | Option exercise | Dispose M | No | No | 0.48 | 4,000 | 1.92 k | 45,087 |
16 Feb 23 | KROS Keros Therapeutics | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 54.38 | 200,000 | 10.88 mm | 200,000 |